President & CEO of Laboratory Corp Of America Holdings (LH, Financial) David P King sold 49,967 shares of LH on 04/23/2018 at an average price of $166.12 a share. The total sale was $8.3 million.
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development. Laboratory Corp of America Holdings has a market cap of $17.62 billion; its shares were traded at around $172.71 with a P/E ratio of 14.15 and P/S ratio of 1.70. Laboratory Corp of America Holdings had annual average EBITDA growth of 7.60% over the past ten years. GuruFocus rated Laboratory Corp of America Holdings the business predictability rank of 5-star.
CEO Recent Trades:
- President & CEO David P King sold 49,967 shares of LH stock on 04/23/2018 at the average price of $166.12. The price of the stock has increased by 3.97% since.
For the complete insider trading history of LH, click here
.
